Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 6
2016 4
2017 2
2018 2
2019 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Congenital urogenital abnormalities in children with congenital hypothyroidism.
Yousefi Chaijan P, Dorreh F, Sharafkhah M, Amiri M, Ebrahimimonfared M, Rafeie M, Safi F. Yousefi Chaijan P, et al. Among authors: sharafkhah m. Med J Islam Repub Iran. 2017 Jan 30;31:7. doi: 10.18869/mjiri.31.7. eCollection 2017. Med J Islam Repub Iran. 2017. PMID: 28638814 Free PMC article.
Attention-deficit/hyperactivity disorder in children undergoing peritoneal dialysis.
Yousefichaijan P, Sharafkhah M, Vazirian S, Seyedzadeh A, Rafeie M, Salehi B, Amiri M, Ebrahimimonfared M. Yousefichaijan P, et al. Among authors: sharafkhah m. Nephrourol Mon. 2015 Mar 20;7(2):e24427. doi: 10.5812/numonthly.24427. eCollection 2015 Mar. Nephrourol Mon. 2015. PMID: 25830120 Free PMC article.
Does the Serum Expression Level of High-Mobility Group Box 1 (HMGB1) in Multiple Sclerosis Patients have a Relationship with Physical and Psychological Status? A 12-Month Follow-Up Study on Newly Diagnosed MS Patients.
Sharafkhah M, Mosayebi G, Massoudifar A, Seddigh SH, Abdolrazaghnejad A, Alamdara MA, Mokarian P, Mohammadbeigi A, Ebrahimi-Monfared M. Sharafkhah M, et al. Neurol India. 2022 Jan-Feb;70(1):238-248. doi: 10.4103/0028-3886.338707. Neurol India. 2022. PMID: 35263889 Free article.
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study.
Sharafkhah M, Aghakarim Alamdar M, Massoudifar A, Abdolrazaghnejad A, Ebrahimi-Monfared M, Saber R, Mohammadbeigi A. Sharafkhah M, et al. Int Clin Psychopharmacol. 2019 Sep;34(5):222-233. doi: 10.1097/YIC.0000000000000267. Int Clin Psychopharmacol. 2019. PMID: 31058716 Clinical Trial.
18 results